Leptospirosis is a zoonosis of worldwide distribution which causes an acute febrile illness in humans and in some domestic animals. Leptospira spp. are maintained asymptomatically in the reservoir hosts, including a variety of wild and domestic animals (11) . The antibiotics used primarily for the treatment of leptospirosis are penicillin or tetracycline (TC) (3, 6, 11) ; however, the effectiveness of such treatment is controversial, especially for patients with late-stage disease (9, 10) . Other antimicrobial agents have been shown to be active against leptospires in vitro (1, 7), but they have not been used clinically. Recently, several new carboxyquinolones have been developed; these drugs are known to have a broad spectrum of antimicrobial activity and to be well absorbed by the oral route of administration (2) . In addition, ciprofloxacin has been shown to be effective against Leptospira interrogans in an animal model (8) (4) . Antimicrobial agents tested were Q-35 [1-cycloprophyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperdin-1-yl)-4-oxoquinoline-3-carboxylic acid dihydrate] (Chugai Pharmaceutical Co., Tokyo, Japan), norfloxacin (NFLX; Kyorin Pharmaceutical Co., Tokyo, Japan), ofloxacin (OFLX; Daiichi Pharmaceutical Co., Tokyo, Japan), ciprofloxacin (CPFX; Bayer Pharmaceutical Co., Osaka, Japan), tosufloxacin (TFLX; Toyama Chemistry * Corresponding author.
Co., Tokyo, Japan), and tetracycline (Lederle Co., Tokyo, Japan). The activity of each drug against these leptospires was examined by a broth macrodilution technique. Drugs tested were standard powders which were kept at 4°C. Dilutions of drugs were prepared as aqueous solutions in a minimum volume of distilled water and diluted with phosphate-buffered saline to a concentration of 1 mg/ml. On the basis of stability data, drug preparations were freshly prepared before use or were prepared as stock solutions and stored at -40°C. Serial twofold dilutions of each drug starting from 25 ,ug/ml were prepared in tubes containing 2 ml of TPB. Tubes were inoculated with leptospires (final inoculum, 5 x 106/ml) from logarithmic-phase cells and incubated at 30°C in air for 7 days. To study the effects of Q-35 on the growth of L. interrogans serogroup Icterohaemorrhagiae, leptospires were counted with a modified Neubauer chamber under dark-field microscopy on days 2, 5, and 7 of incubation with the drug. The MIC of each drug was defined as the lowest concentration which inhibited visible growth (turbidity) at the seventh day of incubation. The culture tubes were diluted 10-fold on the seventh day of incubation and observed under dark-field microscopy to estimate the number of leptospires. After quantitative determination of the MIC, 10 ,ul of the drug-exposed culture was Q-35 inhibited the growth of leptospires at a concentration of >0.10 ,ug/ml after 7 days of incubation as judged by direct cell count and turbidity measurements (Fig. 1 ). Leptospires at a concentration greater than 5 x 107 cells per ml produced visibly turbid cultures. The optical density at 560 nm at day 7 in drug-free culture was 0.047, which corresponded to 1.4 x 10' leptospires per ml. The MIC of Q-35 determined from this experiment was 0.10 ,ug/ml for L. interrogans serogroup Icterohaemorrhagiae RGA. Growth kinetics of this serogroup were also tested in the presence of TC and OFLX (data not shown); the MICs of TC and OFLX were 0.10 and 0.20 ,ug/ml, respectively, for this strain.
MICs and MBCs of each drug for five serogroups of L.
interrogans are shown in Table 1 . MICs of Q-35 for five Leptospira strains were within the range of 0.05 to 0.10 pg/ml. Q-35, OFLX, CPFX, TFLX, and TC showed similar MICs, while NFLX was less active.
MBCs of each drug for five serogroups of L. interrogans are also shown in Table 1 . MBCs of each drug varied depending on the strains used. In particular, L. interrogans serogroup Icterohaemorrhagiae was relatively resistant to the bactericidal activity of each drug, and the MBC of Q-35 was four times higher than that of TC for that serogroup.
MBCs of Q-35 for the other four serogroups of L. interrogans ranged from 1.56 to 3.13 ,ug/ml, and similar values were obtained for CPFX, TFLX, and TC. NFLX and OFLX were found to be significantly less active compared with the other drugs.
Turbidity measurement and microscopic observation were used in this study to (8) . This discrepancy might be due to the different experimental procedures employed in the two studies. In our study, a final inoculum of 5 x 106 cells per ml was used, which was 10 times higher than that of Shalit et al. This might produce the observed differences in our MBCs. Another possible explanation might be the difference in strains of serogroup Icterohaemorrhagiae used in the two studies.
The data presented in this paper show that new carboxyquinolone drugs including the newly developed Q-35 are active against L. interrogans as evaluated by MICs, although MBCs were usually 10-to 100-fold higher than MICs.
